[William S. Dodge is Professor of Law and Associate Dean for Research at the University of California, Hastings College of the Law. From August 2011 to July 2012, he served as Counselor on International Law to the Legal Adviser at the U.S. Department of State, where he worked on the amicus brief of the United States to the Fourth Circuit in Yousuf v. Samantar. The views expressed here are his own and do not necessarily reflect the views of the State Department or of the United States.]
On Monday, Mohamed Ali Samantar filed a cert
petition asking the Supreme Court to review the Fourth Circuit’s decision that he is not entitled to conduct-based immunity in a suit brought under the Alien Tort Statute and Torture Victim Protection Act alleging torture, arbitrary detention, and extrajudicial killing. In 2010, the Supreme Court held in
Samantar v. Yousuf that the Foreign Sovereign Immunities Act (FSIA) did not apply to the immunities of foreign officials, which continue to be governed by federal common law. On remand, the State Department determined that Samantar did not enjoy immunity, the District Court followed the State Department’s determination, and the Court of Appeals affirmed. The Fourth Circuit held: (1) that while State Department determinations of status-based immunity (e.g. head-of-state immunity) are entitled to absolute deference, State Department determinations of conduct-based immunity for official acts are entitled only to substantial weight; and (2) that foreign officials are not entitled to conduct-based immunity for violations of
jus cogens norms. I have previously
explained why I believe that decision to be fundamentally correct.
Samantar’s cert petition argues that the Fourth Circuit’s decision conflicts with the decisions of the Second Circuit in
Matar v. Dichter, the D.C. Circuit in
Belhas v. Ya’alon, and the Seventh Circuit in
Ye v. Zemin, each of which refused to recognize a
jus cogens exception to the immunity at issue. In
Matar, the Second Circuit deferred to the State Department’s determination that the defendant was entitled to conduct-based immunity and refused to override that determination by finding a
jus cogens exception. But in
Samantar, the State Department has determined that the defendant is
not entitled to conduct-based immunity, so the question whether to recognize a
jus cogens exception was never presented.
Belhas was decided on the assumption—now corrected by the Supreme Court’s 2010
Samantar decision—that the Foreign Sovereign Immunities Act (FSIA) governed the immunity of foreign officials and held that there is no
jus cogens exception to the FSIA, a conclusion that prior decisions had reached in suits against states.
Ye held that there was no
jus cogens exception to head-of-state immunity, an immunity that attaches because of an official’s status as a sitting head of state. In each of these cases, the question was whether to recognize an exception to an immunity that had—for one reason or another—already attached.
The question in
Samantar, by contrast, is not whether to recognize a
jus cogens exception to an immunity that has already attached, but the antecedent question whether
jus cogens violations can be taken in an official capacity
so that conduct-based immunity attaches in the first place. As Judge Stephen Williams noted in his concurring opinion in
Belhas, the question whether an immunity attaches is “quite distinct” from the question whether to recognize exceptions to an existing immunity. The Fourth Circuit’s decision in
Samantar is the first Court of Appeals decision to say whether
jus cogens violations can constitute official acts for purposes of conduct-based immunity.
My friend Curt Bradley has
suggested that distinguishing these two questions is just semantics. To see why it is not, it may be useful to step back and consider how immunity generally works. All immunity questions proceed in three basic steps: (1) who is covered, (2) what is covered, and (3) is there an exception. I will use state immunity, status-based immunity, and conduct-based immunity as illustrations, but one could ask the same questions with respect to diplomatic and consular immunities.